Top News: #Drugsafety

 Hear are the top read news for #drugsafety:


ACR: Biosimilars Must Be Tightly Regulated:

Following the approval of the first biosimilar agent in the United States — Zarxio, for the prevention of infections in patients with cancer undergoing chemotherapy — the American College of Rheumatology (ACR) has issued a position statement on biosimilars, given the expectation that there soon may be biosimilars for biologics used in rheumatology. Read more



chantixNew FDA warning for anti-smoking drug Chantix:

The Food and Drug Administration is adding a new warning to Pfizer’s anti-smoking drug Chantix letting patients know the prescription can intensify the effects of drinking alcohol, sometimes leading to aggressive behavior or amnesia. Read more


Recalled over-the-counter medicines distributed by the McNeil Consumer Healthcare division of Johnson & Johnson including St. Joseph's Aspirin tablets, lot AMM365, Motrin Junior Strength tablets, lot APM303, Tylenol Extra Strength caplets, lot AMA008, and Rolaids Freshmint tablets, lot AFA293, are displayed for a photograph in New York, U.S., on Friday, Jan. 15, 2010. Johnson & Johnson expanded its recall of products possibly tainted with a wood chemical to include Rolaids, Motrin, Children's Tylenol and St. Joseph's Aspirin along with some lots of Benadryl allergy tablets and Tylenol caplets as a "precautionary action" after consumer reports of moldy, musty and mildew-like odors in some of the pills. Photographer: Daniel Acker/Bloomberg via Getty ImagesTylenol Maker Admits to Selling Liquid Medicine Contaminated with Metal:

The maker of Tylenol pleaded guilty in a Federal Court on Tuesday to selling liquid medicine contaminated with metal. Read more



Harder-to-abuse OxyContin doesn’t stop addicts:

Prescription painkiller abuse is rampant in the U.S. According to the American Society of Addiction Medicine, 2.1 million Americans live with opioid addiction. As the problem grew out of control in recent years, lawmakers, health officials and drug companies sought ways to curb illicit use of these medications, and one promising solution was to change the way the pills were made.



FDA proposes to let drug companies undermine official safety warnings:

The Food and Drug Administration is proposing to allow pharmaceutical companies to undermine official safety warnings in sales presentations to customers. Read more